Finance

Beta
Lists
TLIK:FRA
Arzneiwerk VIDA AG
€0.21
0.00%
(0.00) 1D
Jul 10, 8:19:13 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TLIK...
Mkt. cap
1.28M
Avg. vol.
121.00
Volume
0.00
52-wk high
€0.59
52-wk low
€0.00
EPS
-€0.09
No. of employees
1
Mkt. cap
1.28M
Avg. vol.
121.00
Volume
0.00
52-wk high
€0.59
52-wk low
€0.00
EPS
-€0.09
No. of employees
1
News stories
From sources across the web
Profile
TELES AG Informationstechnologien is a provider of equipment and services to fixed, fixed-mobile convergence, and Next Generation Networking service providers. The company was founded in 1983 as TELES GmbH by Professor Dr.-Ing. Sigram Schindler in close cooperation with Technische Universität Berlin. Professor Schindler lectured in telecommunications at the university until 1998. In 1997, he was voted High-Tech Manager of the Year by Manager Magazine in Germany. Active in VoIP technology development since 1996, the company's main development and operational focus lies in the areas of IMS and NGN. TELES supplies service providers with complete Class 4 and Class 5 NGN Softswitch. TELES NGN is a standard based, scalable architecture aimed at minimizing integration time and allowing quick deployment. It includes hosted voice functionality which enables residential VoIP services, hosted PBX services, Fixed-Mobile-Convergence, IP Trunking, and additional value added applications. Classical NGN/PSTN applications like Wholesale, Long Distance, and NGN backbone services are also available with this. Wikipedia
About Arzneiwerk VIDA AG
CEOOliver Olbrich
Employees1
Founded1983
Headquarters-
SectorHealth care provider
Websitearzneiwerk.ag
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
40.23K
28.22K
46.00
46.00
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.63K
21.36K
20.86K
20.86K
Operating expense
154.61K
266.00K
-13.70K
-13.70K
Total operating expenses
154.61K
266.00K
-13.70K
-13.70K
Operating income
-114.38K
-237.78K
13.74K
13.74K
Other non operating income
1.00
-2.00
-40.76K
-40.76K
EBT including unusual items
-179.73K
-302.68K
-40.71K
-40.71K
EBT excluding unusual items
-179.73K
-302.68K
-58.06K
-58.06K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
127.74K
244.08K
-34.87K
-34.87K
Net income
-179.73K
-302.68K
-40.71K
-40.71K
Net profit margin
-446.77%
-1,072.56%
-88,504.35%
-88,504.35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
40.00
40.00
Interest expense
-65.35K
-64.90K
-31.08K
-31.08K
Net interest expenses
-65.35K
-64.90K
-31.04K
-31.04K
Depreciation and amortization charges
1.24K
557.00
316.00
316.00
EBITDA
-113.14K
-237.22K
14.06K
14.06K
Gain or loss from assets sale
-
7.98K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer